Navigating resistance to ALK inhibitors in the Lorlatinib Era: a comprehensive perspective on NSCLC.
Article in Expert Review of Anticancer Therapy (April 2024)
The most recent citing publications are shown below. View all 123 publications that cite this research output on Dimensions.
Article in Expert Review of Anticancer Therapy (April 2024)
Article in The Journal of Pathology (April 2024)
Article in Frontiers in Immunology (April 2024)